基于纳米颗粒的植物化学物质用于神经退行性阿尔茨海默病的管理: 更新评论
Basma Youssef1, Ehab A Ibrahim1, Said S Moselhy2
1Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Discover nano
|October 8, 2025
概括
自然植物化学纳米药物为治疗阿尔茨海默病 (AD) 提供了一种有前途的方法. 这种纳米技术增强了跨血脑屏障 (BBB) 的药物输送,提高了治疗效率并减少了神经毒性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,影响全球数百万人,预计到2050年,这种病例将增加三倍.
- 阿尔茨海默病理包括粉样β斑块,团和神经炎症.
- 目前的AD治疗面临重大挑战,包括低功效和药物输送不良的血液-大脑屏障 (BBB).
研究的目的:
- 探索天然植物化学纳米药物对阿尔茨海默病 (AD) 的治疗潜力.
- 审查纳米技术如何改善AD治疗的BBB药物输送系统.
- 评估纳米医学在增加生物可用性和最小化AD中神经毒性的作用.
主要方法:
- 审查现有的关于纳米技术和天然植物化学品在阿尔茨海默病治疗的文献.
- 对药物输送,生物可用性和毒性相关的纳米粒子特性进行分析.
- 探索纳米医学与生物系统的分子级相互作用.
主要成果:
- 纳米粒子在医学上显示出显著的潜力,原因是提高了生物可用性,运输能力和低毒性.
- 基于植物化学的纳米医学可以克服BBB的局限性,以更有效地提供药物.
- 纳米技术提供了一种可行的策略,以改善阿尔茨海默病的治疗结果.
结论:
- 自然植物化学纳米药物为阿尔茨海默病 (AD) 提供了一个有前途的治疗途径.
- 基于纳米技术的方法可以显著提高整个BBB的药物输送,提高治疗效率.
- 对纳米医学的进一步研究有可能开发出具有降低神经毒性的新型和有效的AD疗法.
相关概念视频
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K


